If you made any changes in Pure these will be visible here soon.

Personal profile

Area of academic expertise - outline

Cardiovascular disease is the single leading cause of death and disability in the world (responsible for almost 1 in every 3 deaths). Dysfunction of endothelial cells, a cell type that lines the surface of every blood vessel, plays a critical role in the development and progression of cardiovascular disease but as yet we do not have effective therapeutic means to protect or restore activity of this key cell type. My research focuses on the role of endothelial cells as a regulator of vascular smooth muscle cell activity and how this can be is disrupted by the inflammatory conditions that occur in diseases such as obesity, diabetes mellitus, preeclampsia and rheumatoid arthritis. Understanding more about how endothelial cells become dysfunctional will greatly enhance our insight into the cellular processes that underlie the cardiovascular disease and help find means to prevent the its devastating consequences, such as heart attack and stroke.

I have established an ex vivo vascular assessment suite allowing the determination of both macro- and micro-vascular reactivity i.e. real-time recording of contraction and relaxation of isolated blood vessels. The key advantage of ex vivo analysis of vascular reactivity is that the blood vessel is free from hormonal or neural influence and in an environment which allows for accurate probing of cellular pathways. Furthermore, through my partnership with the Centre of Musculoskeletal Science at Glasgow University, we can also determine blood flow in vivo with use of a laser Doppler technique. Moreover, access to techniques such as PCR, immunohistochemistry, western blotting and ELISA allows for a multi-faceted multi-disciplinary approach to exploring vascular dysfunction.

Current research activities

My current research investigates the mechanisms underlying vascular dysfunction found in several diverse disorders. Specifically we are exploring the role of the angiotensin 2 type 1 receptor as a mediator of vascular dysfunction found in rheumatoid arthritis. Furthermore we are analysing the role of adipose tissue as a regulator of vascular reactivity and how with can be modified by proteinase-activated receptor 2 in conditions of obesity. In addition we are analysing human placental artery function in relation to interleukin levels to investigate potential a route by which preeclampsia may develop. Moreover we are examining flavonoids and other dietary supplements for their putative protective action against the detrimental influence of glucose vascular reactivity.

Desired research direction

My aim is to garner further insight into the cellular mechanisms underlying vascular disorder and to utilise this knowledge to highlight novel routes of therapy and, along with industrial partners, develop targeted pharmaceutical interventions to prevent or alleviate this most devastating of diseases.


  • QP Physiology
  • Cardiovascular disease
  • Endothelium
  • Nitric Oxide
  • AT1R
  • Inflammation

Fingerprint Dive into the research topics where Andrew MacKenzie is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 9 Similar Profiles
Angiotensin Type 1 Receptor Medicine & Life Sciences
Freund's Adjuvant Medicine & Life Sciences
Blood Vessels Medicine & Life Sciences
Rheumatoid Arthritis Medicine & Life Sciences
Endothelium Medicine & Life Sciences
Endothelial Cells Medicine & Life Sciences
Losartan Medicine & Life Sciences
Experimental Arthritis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2008 2018

  • 5 Article
  • 2 Conference contribution
  • 2 Poster
  • 1 Meeting Abstract

Assessment of the effects of exercise on a murine model of OA

Huesa, C., Dunning, L., Macdougall, K., Ortiz, A., Villaluz, M. M., Fegen, M., Crilly, A., Litherland, G., MacKenzie, A., van't Hof, R., Goodyear, C. & Lockhart, J., 8 Jan 2018, (Accepted/In press).

Research output: Contribution to conferencePoster

Tibial Meniscus
10 Downloads (Pure)
Open Access
Angiotensin Type 1 Receptor
Freund's Adjuvant
Rheumatoid Arthritis

Gender specific generation of nitroxyl (HNO) from rat endothelium

Hamilton, K. & MacKenzie, A., Aug 2015, In : Vascular Pharmacology. 71, p. 208-214

Research output: Contribution to journalArticle

Sex differences in vascular endothelial cell function reveal a gender specific role for nitroxyl

Hamilton, K. & MacKenzie, A., 2012.

Research output: Contribution to conferencePoster

Open Access
Sex Characteristics
Endothelial Cells
Blood Vessels



UWS STARS Outstanding Teaching (Highly Commended)

Andrew MacKenzie (Recipient), 2019

Prize: Prize (including medals and awards)


Activities 2012 2019

International Journal of Molecular Sciences (Journal)

Andrew MacKenzie (Peer reviewer)

Activity: Publication peer-review and editorial workPublication peer-review

Glasgow Science Festival - “Smashing Science @UWS"

Andrew MacKenzie (Participant)
6 Jun 2019

Activity: OtherTypes of Public engagement and outreach - Festival/Exhibition

BREATH Annual Conference

John Lockhart (Member of programme committee), Gary Litherland (Invited speaker), Anne Crilly (Invited speaker), Carl Goodyear (Invited speaker), Iain McLellan (Invited speaker), Craig Williams (Invited speaker), William MacKay (Invited speaker), Andrew MacKenzie (Invited speaker), Joanna Brzeszczynska (Invited speaker), Lynette Dunning (Invited speaker), Carly Woods (Invited speaker), Mari Bailo (Invited speaker), Mark Thomas (Invited speaker), Kirsty McCallum (Invited speaker), Kimberly Black (Invited speaker), Fawziye Tarhini (Invited speaker), Bryn Short (Invited speaker)
19 Jun 201921 Jun 2019

Activity: Participating in or organising an eventParticipation in conference

Meeting with Glasgow Respiratory Clinicians

John Lockhart (Participant), Andrew MacKenzie (Organiser), Gary Litherland (Participant), Anne Crilly (Participant), William MacKay (Participant), Craig Williams (Participant), Joanna Brzeszczynska (Participant), Mariarca Bailo (Presenter), Kirsty McCallum (Presenter), Bryn Short (Presenter), Kimberly Black (Presenter), Fawziye Tarhini (Presenter), David Anderson (Participant), Hannah Bayes (Participant), Pallavai Bedi (Participant)
8 Feb 2019

Activity: Other

HLS Combined Research Institutes Symposium

John Lockhart (Organiser), Kimberly Black (Speaker), Gary Litherland (Participant), Andrew MacKenzie (Participant)
30 May 2019

Activity: Other


PAR-2 Receptor
Premature Aging
Chronic Obstructive Pulmonary Disease
Tibial Meniscus
Joint Diseases
Angiotensin Type 1 Receptor
Blood Vessels
Rheumatoid Arthritis
Freund's Adjuvant
Tibial Meniscus